Close



Sep 1, 2021 12:36PM
Aug 3, 2021 06:25AM
Jul 16, 2021 10:01AM
Jul 16, 2021 10:00AM
May 18, 2021 06:15AM
May 18, 2021 12:09AM
Apr 27, 2021 06:25AM Lilly Delivers First-Quarter 2021 Financial Results, Adjusts 2021 Financial Guidance
Apr 6, 2021 04:30PM
Apr 6, 2021 04:30PM
Mar 15, 2021 10:13AM
Oct 27, 2020 06:30AM
Mar 2, 2020 06:47AM
Mar 2, 2020 06:45AM
Jan 29, 2020 07:20AM Lilly (LLY) Receives FDA Priority Review for the Selpercatinib NDA
Jan 29, 2020 06:45AM
Sep 5, 2019 03:00PM
Sep 5, 2019 03:00PM
Apr 20, 2017 12:09PM
Jan 31, 2017 06:25AM
Jan 17, 2017 07:20AM
Jan 13, 2017 04:51PM U.S. FDA Extends Review Period for Baricitinib, an Investigational Rheumatoid Arthritis Treatment

12,349 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All